Madrigal Pharmaceuticals, Inc. Announces Participation at Three Upcoming Investor Conferences

Rhea-AI Summary

Madrigal Pharmaceuticals (Nasdaq: MDGL) has announced its participation in three major investor conferences. The company will engage in fireside chats at the UBS Global Healthcare Conference on November 13, 2024 at 2:00 PM EST, the 7th Annual Evercore HealthCONx Conference on December 4, 2024 at 9:35 AM EST, and the Piper Sandler 36th Annual Healthcare Conference on December 5, 2024 at 8:30 AM EST. All presentations will be available via live webcast through Madrigal's Investor Relations Events page.

News Market Reaction – MDGL

+0.18%

1 alert

+0.18% News Effect

On the day this news was published, MDGL gained 0.18%, reflecting a mild positive market reaction.

Data tracked by StockTitan Argus on the day of publication.

CONSHOHOCKEN, Pa., Nov. 06, 2024 (GLOBE NEWSWIRE) -- Madrigal Pharmaceuticals, Inc. (Nasdaq: MDGL) today announced that the company will participate in fireside chats at three upcoming investor conferences:

UBS Global Healthcare Conference 2024
Wednesday, November 13, 2024 at 2:00 P.M. EST
The presentation will be webcast live and may be accessed here.

7th Annual Evercore HealthCONx Conference
Wednesday, December 4, 2024 at 9:35 A.M. EST

Piper Sandler 36th Annual Healthcare Conference
Thursday, December 5, 2024 at 8:30 A.M. EST

The fireside chats will be webcast live and can be accessed by visiting Madrigal’s Investor Relations Events page.

About Madrigal Pharmaceuticals
Madrigal Pharmaceuticals, Inc. (Nasdaq: MDGL) is a biopharmaceutical company focused on delivering therapeutics for nonalcoholic steatohepatitis (NASH), a liver disease with high unmet medical need. Madrigal’s medication, Rezdiffra (resmetirom), is a once-daily, oral, liver-directed THR-β agonist designed to target key underlying causes of NASH. For more information, visit www.madrigalpharma.com.

Investor Contact
Tina Ventura, IR@madrigalpharma.com

Media Contact
Christopher Frates, media@madrigalpharma.com

FAQ

When is Madrigal Pharmaceuticals (MDGL) presenting at the UBS Global Healthcare Conference 2024?

Madrigal Pharmaceuticals will present at the UBS Global Healthcare Conference on Wednesday, November 13, 2024 at 2:00 PM EST.

Which investor conferences will Madrigal Pharmaceuticals (MDGL) attend in December 2024?

Madrigal Pharmaceuticals will attend the Evercore HealthCONx Conference on December 4 and the Piper Sandler Healthcare Conference on December 5, 2024.

How can investors access Madrigal Pharmaceuticals' (MDGL) conference presentations?

Investors can access the fireside chat presentations through live webcasts available on Madrigal's Investor Relations Events page.